The global Allergy Immunotherapy market was valued at US$ 1867 million in 2025 and is anticipated to reach US$ 2982 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Allergy Immunotherapy Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Allergy Immunotherapy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response. The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The global allergy immunotherapy market is primarily driven by the rising prevalence of allergic conditions, such as allergic rhinitis, asthma, and food allergies, which affect hundreds of millions of individuals worldwide. Growing awareness about long-term treatment options and the effectiveness of immunotherapy in providing sustained symptom relief is increasing its adoption. Additionally, advancements in diagnostic techniques, improved formulations such as sublingual tablets, and support from regulatory authorities have facilitated market growth. The increasing demand for personalized medicine and a shift toward disease-modifying therapies are further propelling the market forward.

Despite its therapeutic potential, the allergy immunotherapy market faces several challenges. The long treatment duration—often lasting three to five years—can lead to poor patient compliance and high dropout rates. High upfront costs and limited reimbursement in some regions restrict accessibility for many patients. Moreover, the requirement for specialized healthcare infrastructure and trained professionals, especially for subcutaneous immunotherapy, limits adoption in low-resource settings. Safety concerns, including the risk of systemic allergic reactions, also hinder broader acceptance, particularly among pediatric and elderly populations. These barriers collectively slow market penetration and limit the therapy’s full potential.

This report delivers a comprehensive overview of the global Allergy Immunotherapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Allergy Immunotherapy. The Allergy Immunotherapy market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Allergy Immunotherapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Allergy Immunotherapy Market Report

Report Metric	Details
Report Name	Allergy Immunotherapy Market
Accounted market size in 2025	US$ 1867 million
Forecasted market size in 2032	US$ 2982 million
CAGR	7.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Subcutaneous Immunotherapy Sublingual Immunotherapy
by Application	Allergic Rhinitis Allergic Asthma Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, WOLW Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Allergy Immunotherapy manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Allergy Immunotherapy sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Allergy Immunotherapy Market growing?

Ans: The Allergy Immunotherapy Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Allergy Immunotherapy Market size in 2032?

Ans: The Allergy Immunotherapy Market size in 2032 will be US$ 2982 million.

Who are the main players in the Allergy Immunotherapy Market report?

Ans: The main players in the Allergy Immunotherapy Market are ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, WOLW Pharma

What are the Application segmentation covered in the Allergy Immunotherapy Market report?

Ans: The Applications covered in the Allergy Immunotherapy Market report are Allergic Rhinitis, Allergic Asthma, Others

What are the Type segmentation covered in the Allergy Immunotherapy Market report?

Ans: The Types covered in the Allergy Immunotherapy Market report are Subcutaneous Immunotherapy, Sublingual Immunotherapy

1 Allergy Immunotherapy Market Overview

1.1 Product Definition

1.2 Allergy Immunotherapy by Type

1.2.1 Global Allergy Immunotherapy Market Value by Type: 2025 vs 2032

1.2.2 Subcutaneous Immunotherapy

1.2.3 Sublingual Immunotherapy

1.3 Allergy Immunotherapy by Application

1.3.1 Global Allergy Immunotherapy Market Value by Application: 2025 vs 2032

1.3.2 Allergic Rhinitis

1.3.3 Allergic Asthma

1.3.4 Others

1.4 Global Allergy Immunotherapy Market Size Estimates and Forecasts

1.4.1 Global Allergy Immunotherapy Revenue 2021–2032

1.4.2 Global Allergy Immunotherapy Sales 2021–2032

1.4.3 Global Allergy Immunotherapy Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Allergy Immunotherapy Market Competition by Manufacturers

2.1 Global Allergy Immunotherapy Sales Market Share by Manufacturers (2021–2026)

2.2 Global Allergy Immunotherapy Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Allergy Immunotherapy Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Allergy Immunotherapy, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Allergy Immunotherapy, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Allergy Immunotherapy, Product Types and Applications

2.7 Global Key Manufacturers of Allergy Immunotherapy, Date of Entry into the Industry

2.8 Global Allergy Immunotherapy Market Competitive Situation and Trends

2.8.1 Global Allergy Immunotherapy Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Allergy Immunotherapy Players Market Share by Revenue

2.8.3 Global Allergy Immunotherapy Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Allergy Immunotherapy Market Scenario by Region

3.1 Global Allergy Immunotherapy Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Allergy Immunotherapy Sales by Region: 2021–2032

3.2.1 Global Allergy Immunotherapy Sales by Region: 2021–2026

3.2.2 Global Allergy Immunotherapy Sales by Region: 2027–2032

3.3 Global Allergy Immunotherapy Revenue by Region: 2021–2032

3.3.1 Global Allergy Immunotherapy Revenue by Region: 2021–2026

3.3.2 Global Allergy Immunotherapy Revenue by Region: 2027–2032

3.4 North America Allergy Immunotherapy Market Facts & Figures by Country

3.4.1 North America Allergy Immunotherapy Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Allergy Immunotherapy Sales by Country (2021–2032)

3.4.3 North America Allergy Immunotherapy Revenue by Country (2021–2032)

3.5 Europe Allergy Immunotherapy Market Facts & Figures by Country

3.5.1 Europe Allergy Immunotherapy Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Allergy Immunotherapy Sales by Country (2021–2032)

3.5.3 Europe Allergy Immunotherapy Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Allergy Immunotherapy Market Facts & Figures by Region

3.6.1 Asia Pacific Allergy Immunotherapy Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Allergy Immunotherapy Sales by Region (2021–2032)

3.6.3 Asia Pacific Allergy Immunotherapy Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Allergy Immunotherapy Market Facts & Figures by Country

3.7.1 Latin America Allergy Immunotherapy Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Allergy Immunotherapy Sales by Country (2021–2032)

3.7.3 Latin America Allergy Immunotherapy Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country

3.8.1 Middle East and Africa Allergy Immunotherapy Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2021–2032)

3.8.3 Middle East and Africa Allergy Immunotherapy Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Allergy Immunotherapy Sales by Type (2021–2032)

4.1.1 Global Allergy Immunotherapy Sales by Type (2021–2026)

4.1.2 Global Allergy Immunotherapy Sales by Type (2027–2032)

4.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2021–2032)

4.2 Global Allergy Immunotherapy Revenue by Type (2021–2032)

4.2.1 Global Allergy Immunotherapy Revenue by Type (2021–2026)

4.2.2 Global Allergy Immunotherapy Revenue by Type (2027–2032)

4.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2021–2032)

4.3 Global Allergy Immunotherapy Price by Type (2021–2032)

5 Segment by Application

5.1 Global Allergy Immunotherapy Sales by Application (2021–2032)

5.1.1 Global Allergy Immunotherapy Sales by Application (2021–2026)

5.1.2 Global Allergy Immunotherapy Sales by Application (2027–2032)

5.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2021–2032)

5.2 Global Allergy Immunotherapy Revenue by Application (2021–2032)

5.2.1 Global Allergy Immunotherapy Revenue by Application (2021–2026)

5.2.2 Global Allergy Immunotherapy Revenue by Application (2027–2032)

5.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2021–2032)

5.3 Global Allergy Immunotherapy Price by Application (2021–2032)

6 Key Companies Profiled

6.1 ALK-Abello

6.1.1 ALK-Abello Company Information

6.1.2 ALK-Abello Description and Business Overview

6.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio

6.1.5 ALK-Abello Recent Developments/Updates

6.2 Stallergenes Greer

6.2.1 Stallergenes Greer Company Information

6.2.2 Stallergenes Greer Description and Business Overview

6.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio

6.2.5 Stallergenes Greer Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Merck Allergy Immunotherapy Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Allergy Therapeutics

6.4.1 Allergy Therapeutics Company Information

6.4.2 Allergy Therapeutics Description and Business Overview

6.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio

6.4.5 Allergy Therapeutics Recent Developments/Updates

6.5 HAL

6.5.1 HAL Company Information

6.5.2 HAL Description and Business Overview

6.5.3 HAL Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 HAL Allergy Immunotherapy Product Portfolio

6.5.5 HAL Recent Developments/Updates

6.6 Holister Stier

6.6.1 Holister Stier Company Information

6.6.2 Holister Stier Description and Business Overview

6.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Holister Stier Allergy Immunotherapy Product Portfolio

6.6.5 Holister Stier Recent Developments/Updates

6.7 Leti

6.7.1 Leti Company Information

6.7.2 Leti Description and Business Overview

6.7.3 Leti Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Leti Allergy Immunotherapy Product Portfolio

6.7.5 Leti Recent Developments/Updates

6.8 WOLW Pharma

6.8.1 WOLW Pharma Company Information

6.8.2 WOLW Pharma Description and Business Overview

6.8.3 WOLW Pharma Allergy Immunotherapy Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 WOLW Pharma Allergy Immunotherapy Product Portfolio

6.8.5 WOLW Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Allergy Immunotherapy Industry Chain Analysis

7.2 Allergy Immunotherapy Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Allergy Immunotherapy Production Mode & Process Analysis

7.4 Allergy Immunotherapy Sales and Marketing

7.4.1 Allergy Immunotherapy Sales Channels

7.4.2 Allergy Immunotherapy Distributors

7.5 Allergy Immunotherapy Customer Analysis

8 Allergy Immunotherapy Market Dynamics

8.1 Allergy Immunotherapy Industry Trends

8.2 Allergy Immunotherapy Market Drivers

8.3 Allergy Immunotherapy Market Challenges

8.4 Allergy Immunotherapy Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Allergy Immunotherapy Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Allergy Immunotherapy Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Allergy Immunotherapy Market Competitive Situation by Manufacturers in 2025

Table 4. Global Allergy Immunotherapy Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Allergy Immunotherapy Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Allergy Immunotherapy Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Allergy Immunotherapy Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Allergy Immunotherapy Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Allergy Immunotherapy, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Allergy Immunotherapy, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Allergy Immunotherapy, Product Types and Applications

Table 12. Global Key Manufacturers of Allergy Immunotherapy, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Allergy Immunotherapy Companies by Tier (Tier 1, Tier 2, Tier 3), based on Allergy Immunotherapy Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Allergy Immunotherapy Sales by Region (K Units), 2021–2026

Table 18. Global Allergy Immunotherapy Sales Market Share by Region (2021–2026)

Table 19. Global Allergy Immunotherapy Sales by Region (K Units), 2027–2032

Table 20. Global Allergy Immunotherapy Sales Market Share by Region (2027–2032)

Table 21. Global Allergy Immunotherapy Revenue by Region (US$ Million), 2021–2026

Table 22. Global Allergy Immunotherapy Revenue Market Share by Region (2021–2026)

Table 23. Global Allergy Immunotherapy Revenue by Region (US$ Million), 2027–2032

Table 24. Global Allergy Immunotherapy Revenue Market Share by Region (2027–2032)

Table 25. North America Allergy Immunotherapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Allergy Immunotherapy Sales by Country (K Units), 2021–2026

Table 27. North America Allergy Immunotherapy Sales by Country (K Units), 2027–2032

Table 28. North America Allergy Immunotherapy Revenue by Country (US$ Million), 2021–2026

Table 29. North America Allergy Immunotherapy Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Allergy Immunotherapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Allergy Immunotherapy Sales by Country (K Units), 2021–2026

Table 32. Europe Allergy Immunotherapy Sales by Country (K Units), 2027–2032

Table 33. Europe Allergy Immunotherapy Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Allergy Immunotherapy Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Allergy Immunotherapy Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Allergy Immunotherapy Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Allergy Immunotherapy Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Allergy Immunotherapy Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Allergy Immunotherapy Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Allergy Immunotherapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Allergy Immunotherapy Sales by Country (K Units), 2021–2026

Table 42. Latin America Allergy Immunotherapy Sales by Country (K Units), 2027–2032

Table 43. Latin America Allergy Immunotherapy Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Allergy Immunotherapy Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Allergy Immunotherapy Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Allergy Immunotherapy Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Allergy Immunotherapy Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Allergy Immunotherapy Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Allergy Immunotherapy Revenue by Country (US$ Million), 2027–2032

Table 50. Global Allergy Immunotherapy Sales (K Units) by Type (2021–2026)

Table 51. Global Allergy Immunotherapy Sales (K Units) by Type (2027–2032)

Table 52. Global Allergy Immunotherapy Sales Market Share by Type (2021–2026)

Table 53. Global Allergy Immunotherapy Sales Market Share by Type (2027–2032)

Table 54. Global Allergy Immunotherapy Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Allergy Immunotherapy Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Allergy Immunotherapy Revenue Market Share by Type (2021–2026)

Table 57. Global Allergy Immunotherapy Revenue Market Share by Type (2027–2032)

Table 58. Global Allergy Immunotherapy Price (US$/Unit) by Type (2021–2026)

Table 59. Global Allergy Immunotherapy Price (US$/Unit) by Type (2027–2032)

Table 60. Global Allergy Immunotherapy Sales (K Units) by Application (2021–2026)

Table 61. Global Allergy Immunotherapy Sales (K Units) by Application (2027–2032)

Table 62. Global Allergy Immunotherapy Sales Market Share by Application (2021–2026)

Table 63. Global Allergy Immunotherapy Sales Market Share by Application (2027–2032)

Table 64. Global Allergy Immunotherapy Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Allergy Immunotherapy Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Allergy Immunotherapy Revenue Market Share by Application (2021–2026)

Table 67. Global Allergy Immunotherapy Revenue Market Share by Application (2027–2032)

Table 68. Global Allergy Immunotherapy Price (US$/Unit) by Application (2021–2026)

Table 69. Global Allergy Immunotherapy Price (US$/Unit) by Application (2027–2032)

Table 70. ALK-Abello Company Information

Table 71. ALK-Abello Description and Business Overview

Table 72. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. ALK-Abello Allergy Immunotherapy Product

Table 74. ALK-Abello Recent Developments/Updates

Table 75. Stallergenes Greer Company Information

Table 76. Stallergenes Greer Description and Business Overview

Table 77. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Stallergenes Greer Allergy Immunotherapy Product

Table 79. Stallergenes Greer Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Merck Allergy Immunotherapy Product

Table 84. Merck Recent Developments/Updates

Table 85. Allergy Therapeutics Company Information

Table 86. Allergy Therapeutics Description and Business Overview

Table 87. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Allergy Therapeutics Allergy Immunotherapy Product

Table 89. Allergy Therapeutics Recent Developments/Updates

Table 90. HAL Company Information

Table 91. HAL Description and Business Overview

Table 92. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. HAL Allergy Immunotherapy Product

Table 94. HAL Recent Developments/Updates

Table 95. Holister Stier Company Information

Table 96. Holister Stier Description and Business Overview

Table 97. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Holister Stier Allergy Immunotherapy Product

Table 99. Holister Stier Recent Developments/Updates

Table 100. Leti Company Information

Table 101. Leti Description and Business Overview

Table 102. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Leti Allergy Immunotherapy Product

Table 104. Leti Recent Developments/Updates

Table 105. WOLW Pharma Company Information

Table 106. WOLW Pharma Description and Business Overview

Table 107. WOLW Pharma Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. WOLW Pharma Allergy Immunotherapy Product

Table 109. WOLW Pharma Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Allergy Immunotherapy Distributors List

Table 113. Allergy Immunotherapy Customers List

Table 114. Allergy Immunotherapy Market Trends

Table 115. Allergy Immunotherapy Market Drivers

Table 116. Allergy Immunotherapy Market Challenges

Table 117. Allergy Immunotherapy Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Allergy Immunotherapy

Figure 2. Global Allergy Immunotherapy Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Allergy Immunotherapy Market Share by Type: 2025 & 2032

Figure 4. Subcutaneous Immunotherapy Product Picture

Figure 5. Sublingual Immunotherapy Product Picture

Figure 6. Global Allergy Immunotherapy Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Allergy Immunotherapy Market Share by Application: 2025 & 2032

Figure 8. Allergic Rhinitis

Figure 9. Allergic Asthma

Figure 10. Others

Figure 11. Global Allergy Immunotherapy Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Allergy Immunotherapy Market Size (US$ Million), 2021–2032

Figure 13. Global Allergy Immunotherapy Sales (K Units), 2021–2032

Figure 14. Global Allergy Immunotherapy Average Price (US$/Unit), 2021–2032

Figure 15. Allergy Immunotherapy Report Years Considered

Figure 16. Allergy Immunotherapy Sales Share by Manufacturers in 2025

Figure 17. Global Allergy Immunotherapy Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Allergy Immunotherapy Players: Market Share by Revenue in Allergy Immunotherapy in 2025

Figure 19. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Allergy Immunotherapy Sales Market Share by Country (2021–2032)

Figure 22. North America Allergy Immunotherapy Revenue Market Share by Country (2021–2032)

Figure 23. Europe Allergy Immunotherapy Sales Market Share by Country (2021–2032)

Figure 24. Europe Allergy Immunotherapy Revenue Market Share by Country (2021–2032)

Figure 25. Germany Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. France Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. U.K. Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. Italy Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Russia Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Asia Pacific Allergy Immunotherapy Sales Market Share by Region (2021–2032)

Figure 31. Asia Pacific Allergy Immunotherapy Revenue Market Share by Region (2021–2032)

Figure 32. China Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Japan Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. South Korea Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. India Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Australia Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. China Taiwan Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Indonesia Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Thailand Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Malaysia Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Latin America Allergy Immunotherapy Sales Market Share by Country (2021–2032)

Figure 42. Latin America Allergy Immunotherapy Revenue Market Share by Country (2021–2032)

Figure 43. Mexico Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Brazil Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Argentina Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2021–2032)

Figure 47. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Country (2021–2032)

Figure 48. Turkey Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Saudi Arabia Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. UAE Allergy Immunotherapy Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Global Sales Market Share of Allergy Immunotherapy by Type (2021–2032)

Figure 52. Global Revenue Market Share of Allergy Immunotherapy by Type (2021–2032)

Figure 53. Global Allergy Immunotherapy Price (US$/Unit) by Type (2021–2032)

Figure 54. Global Sales Market Share of Allergy Immunotherapy by Application (2021–2032)

Figure 55. Global Revenue Market Share of Allergy Immunotherapy by Application (2021–2032)

Figure 56. Global Allergy Immunotherapy Price (US$/Unit) by Application (2021–2032)

Figure 57. Allergy Immunotherapy Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Allergy Shots Market Research Report 2024

Global Food Allergy Vaccine Market Research Report 2024

Global Sublingual Allergy Immunotherapy Market Research Report 2024

Global Asthma Allergy Treatment Market Insights Forecast to 2030

Global Pollens Allergy Shot Market Research Report 2024

Global Skin Allergy Treatment Market Insights Forecast to 2030

Global Allergy Medicine Market Research Report 2024

Global Seafood Allergy Treatment Market Research Report 2024

Global Milk Allergy Treatment Market Research Report 2024

Global Allergy Reagent Market Research Report 2024

Global Immune System Allergy Treatment Market Research Report 2025

Global Allergy Apps Market Research Report 2024

Global Allergy Rhinitis Spray Market Research Report 2024

Global Human Allergy Treatment Market Research Report 2025

Global Cell Based Immunotherapy Market Research Report 2024

Global Food Allergy Treatment Market Research Report 2024

Global Seafood Allergy Vaccine Market Research Report 2024

Global Ragweed Pollen Allergy Treatment Market Research Report 2025

Global Grass Pollen Allergy Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions